Adaptin Bio (APTN) Non-Current Debt (2022 - 2024)
Adaptin Bio (APTN) posted Non-Current Debt of $31000.0 for Q3 2024, up 10.71% sequentially from $28000.0 in Q2 2024, and up 63.16% YoY from $19000.0 in Q4 2023.
Adaptin Bio (APTN) Non-Current Debt (2022 - 2024) Analysis & Trends
Adaptin Bio has reported Non-Current Debt for 3 years, with the latest figure at $31000.0 in Q3 2024.
- Quarterly Non-Current Debt rose 63.16% year-over-year to $31000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $31000.0 (up 63.16% YoY) and the FY2023 annual result came in at $10000.0, up 100.0% from the prior year.
- Non-Current Debt climbed to $31000.0 in Q3 2024 per APTN's latest filing, from $28000.0 in the prior quarter.
- Over five years, Non-Current Debt peaked at $81219.0 in Q1 2024 and troughed at $5000.0 in Q4 2022.
- A 3-year average of $29036.5 and a median of $23500.0 in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2023 and 2024: Non-Current Debt jumped 100.0% in 2023, then surged 63.16% in 2024.
- Over 3 years, Non-Current Debt stood at $5000.0 in 2022, then surged by 100.0% to $10000.0 in 2023, then soared by 210.0% to $31000.0 in 2024.
- According to Business Quant data, Non-Current Debt over the past three periods registered $31000.0, $28000.0, and $81219.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 31,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 81,219.00 |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Dec 31, 2022 | 5,000.00 |